Article | May 8, 2014

Costa Rica Back In Business For Medical Research

Source: QuickSTAT

By Dave Murphym Regional Director of Life Sciences, U.S. Quick Group of Companies

Green light given to the continuation of clinical trials and medical research.

After 4 years of prohibition, Laura Chinchilla, President of the Republic of Costa Rica, signed new legislation on April 22, 2014, which allows the private, academic and public sector to once again produce new drugs and medical devices--a breakthrough for the scientific community in the country.

 

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online